Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Protara Therapeutics Inc (TARA)

NASDAQ
Currency in USD
Disclaimer
3.050
+0.230(+8.16%)
Closed
After Hours
3.0500.000(0.00%)
TARA Scorecard
Earnings results expected in 7 days
Fair Value
Unlock Value
Day's Range
2.7623.050
52 wk Range
1.0405.240
Prev. Close
2.82
Open
2.8
Day's Range
2.762-3.05
52 wk Range
1.04-5.24
Volume
262,558
Average Vol. (3m)
259,184
1-Year Change
-9.62%
Shares Outstanding
11,433,837
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

People Also Watch

3.310
ALIM
-8.82%
0.150
SOPA
-1.06%
19.30
ATNI
-32.80%
1.405
NDLS
+8.08%
How do you feel today about TARA?
Vote to see community's results!
or
  • The FDA: Small-Cap Catalyst Or Small-Cap Killer?
    • ByWall Street Daily
  • PRTO Stock Is Worst Performer On NASDAQ
    • ByFSM News

Protara Therapeutics Inc Company Profile

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company’s lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.